Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Intestinal Fistula 1 Hernia, Ventral 1 Hernia 1 Fibromatosis, Abdominal 1 Desmoid Tumors 1

Interventions

Fluorouracil 155 Oxaliplatin 133 Leucovorin 124 Capecitabine 90 Irinotecan 88 Radiotherapy 63 Bevacizumab 61 Cetuximab 38 Folfox protocol 25 Panitumumab 21 Neoadjuvant Therapy 21 Surgical Procedures, Operative 19 Chemotherapy, Adjuvant 15 Radiation 13 Floxuridine 13 Erlotinib Hydrochloride 13 Early Intervention, Educational 13 IFL protocol 11 Drug Therapy 11 Proctectomy 10 Magnetic Resonance Spectroscopy 10 Counseling 10 Surveys and Questionnaires 8 Sorafenib 8 Psychiatric Rehabilitation 8 Gene Expression Profiling 8 Radiotherapy, Intensity-Modulated 7 Immunohistochemistry 7 Gemcitabine 7 Celecoxib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rectal Neoplasms × strattice × Clear all

NCT01927497 2021-08-17

BIOPEX

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 3 Completed

104 enrolled 8 charts

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡